Skip to main content

February 2016

 

 

academics

 

Clinical research courses

Join Pre-Clinical study to work as Project Assistant at NIN - M.Pharm / M.Sc / B.Pharm | Salary Rs.28,755

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr. McCarrison as its first Director. It was shifted to Hyderabad in 1958.

Vacancy as Pharmacist in various ECHS polyclinics under Station Headquarters - Kochi

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

ECHS invites applications for short listing suitable candidates for following staff on contractual basis in various ECHS polyclinics under Station Headquarters (Army) Kochi for a period of 11 months,  for appointing at short notice as on required basis on  vacancies occurring:

Post: Pharmacist

Research post for B.Pharm/M.Pharm/M.Sc in Chikungunya Vaccine at National Institute of Nutrition

National Institute of Nutrition (NIN) was founded by Sir Robert McCarrison in the year 1918 as ‘Beri-Beri’ Enquiry Unit in a single room laboratory at the Pasteur Institute, Coonoor, Tamil Nadu. Within a short span of seven years, this unit blossomed into a "Deficiency Disease Enquiry" and later in 1928, emerged as full-fledged "Nutrition Research Laboratories" (NRL) with Dr. McCarrison as its first Director. It was shifted to Hyderabad in 1958.

Vacancy for Intern - R&D at Bio-Rad Laboratories

Bio-Rad is looking for an Intern - R&D. Candidate have Prior laboratory experience in academic or industrial research.

Post: Intern - R&D

Working opportunity in Pharmaceuticals Division of Genentech | California, South San Francisco

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.
In March 2009, Genentech became a member of the Roche Group. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.

Post: Principal Technical Manager, Supplier Collaborations

One day National level seminar on ICMPR-2 at H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur

SECOND ONE DAY NATIONAL LEVEL SEMINAR ON
‘INNOVATIVE CONCEPTS AND METHODOLOGIES IN PHARMACEUTICAL   RESEARCH-2’
AND  
“INAUGURATION OF R & D LAB.”
FOLLOWED BY
ASOJ SOFT CAPS PVT. LTD., BARODA SPONSORED
PHARMVENTION AWARD
A research award competition for UG students
on
19th March 2015 

Luminex Corporation announced that it has received medical device licenses from Health Canada's Therapeutic Products Directorate, Medical Devices Bureau for the ARIES® System and ARIES® HSV 1&2 Assay. The ARIES® System and HSV 1&2 Assay previously received FDA clearance in October 2015 and were subsequently launched in the U.S. market.

In an important advancement towards an effective treatment against the deadly Ebola virus disease (EVD), researchers have found that a single monoclonal antibody isolated from a human survivor completely protects monkeys from lethal infection with the virus.

A team of US researcher has found that a laser system already in place to kill brain tumours can also be used to disrupt temporarily the blood-brain barrier enabling the crucial chemotherapy drugs to pass into the brain for up to six weeks.

(adsbygoogle = window.adsbygoogle || []).push({});